{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:05:14Z","timestamp":1771646714943,"version":"3.50.1"},"reference-count":5,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,15]]},"DOI":"10.2169\/internalmedicine.5962-25","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:07:45Z","timestamp":1752098865000},"page":"631-631","source":"Crossref","is-referenced-by-count":0,"title":["Risks and Benefits of Obinutuzumab-based Chemotherapy in the Context of SARS-CoV-2 Infection"],"prefix":"10.2169","volume":"65","author":[{"given":"Kohei","family":"Shiroshita","sequence":"first","affiliation":[{"name":"Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himari","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mamizu H, Tsuji J, Kumagai M, et al. An autopsy for persistent coronavirus disease 2019 pneumonia during follicular lymphoma treatment. Intern Med 64: 2051-2056, 2025.","DOI":"10.2169\/internalmedicine.5283-25"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Galusic D, Basic-Kinda S, Pijuk A, et al. Efficacy and safety of obinutuzumab-chemotherapy combinations in front-line treatment of follicular non-Hodgkin lymphoma during the COVID-19 pandemic: a study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases. Hemasphere 6: e807, 2022.","DOI":"10.1097\/HS9.0000000000000807"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pinto A, Caltagirone M, Battista M, et al. Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma. Br J Haematol 205: 2219-2227, 2024.","DOI":"10.1111\/bjh.19661"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Castellino A, Comba L, Bertolotti L, et al. Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study. Ann Hematol 104: 1655-1667, 2025.","DOI":"10.1007\/s00277-025-06295-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ueda Y, Asakura S, Wada S, Saito T, Yano T. Prolonged COVID-19 in an immunocompromised patient treated with obinutuzumab and bendamustine for follicular lymphoma. Intern Med 61: 2523-2526, 2022.","DOI":"10.2169\/internalmedicine.9136-21"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5962-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:43:14Z","timestamp":1771645394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5962-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5962-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"article-number":"5962-25"}}